Global Biosensor Patent Landscape Report 2024

Patent Landscape Report Coverage

The Global Biosensor Patent Landscape Report provides a comprehensive and in-depth analysis of the patents in this growing industry. The key sections captured in the report for biosensors include a thorough examination of the patent portfolios of key players, covering aspects such as the number of patents and types of technologies patented. It includes the latest trends, geographical distribution of patents, top IP player profiles, technological segmentation, and patent valuation associated with biosensors. The breakdown of patents by technical segments is provided, giving more clarity on the specific areas of innovation within Biosensor technologies.

Key Inclusions:

Patent Valuation Analysis

An evaluation and competitive benchmarking of key members of unique patent families are covered in the analysis for biosensor technologies. The important parameters have been taken into consideration including IP document, year of application, number of citations, time to expiry, and jurisdiction associated with Biosensor.

Analysis of Patent Applications

A comprehensive summary of several patent applications which were filed across different jurisdictions for biosensor and their relative value are covered. The analysis will cover the capital in terms of innovation and type.

Analysis of Granted Patents

Detailed analysis of the granted patents across different jurisdictions for biosensor and their relative value in the IP are covered in the final report. 

Biosensor Patent Outlook

• The increasing prevalence of long-term illnesses like diabetes, heart problems, and cancer is boosting the need for biosensors for ongoing monitoring and treatment. Biosensors offer real-time data that can be used to improve patient outcomes through early detection, continuous management, and individualized treatment.
• The patent applications are boosted with technological developments in biosensor design, such as reduced size, increased sensitivity, and mobile device integration. The functionality and convenience of biosensors are improved for consumers and healthcare professionals by innovations like wearable biosensors and lab-on-a-chip technologies.
• The market for biosensors is being driven by consumers' growing preference for point-of-care (POC) testing because of its ease of use and quick results. POC tests enable quick monitoring and diagnosis in a variety of contexts, including homes, clinics, and emergency care facilities. They are made possible by biosensors.

What is Biosensor?

A biosensor is a tool that uses a measurable signal to identify and quantify biological or chemical substances. It provides precise, real-time data by fusing a physical transducer with a biological component, like an enzyme or antibody. Biosensors are widely used in environmental monitoring, food safety, and medical diagnostics.

The components of biosensors include bioreceptor molecules, biological elements, and transducers. A transducer changes one type of energy into another and is frequently for measurement purposes. A biosensor combines a transducer and biological component to identify a specific biological material. When combined, they provide accurate and instantaneous biological process monitoring by converting biological interactions into quantifiable signals.

Biosensor Industry Growth Drivers

Advancements in Technology is Expected to Boost the Patent Industry Growth

The market expansion is fueled by technological developments in biosensor design, such as reduced size, increased sensitivity, and integration with digital platforms. This field's innovations improve the usability and accessibility of biosensors. For instance, the Freestyle Libre 3 system by Abbott Laboratories comes with a smaller, more covert sensor and enhanced accuracy of real-time glucose monitoring. The incorporation of digital platforms facilitates the easy monitoring and administration of data, demonstrating notable advancements in biosensor technology. Patents covering these technologies are crucial for companies and thus impact the biosensor patent landscape. There were 3,867 patents granted in 2022 which increased to 3,950 patents by 2023.

Growing Demand for Point-of-Care Testing is Expected to Propel Biosensor Patent Industry

The biosensor market is being driven by consumers' growing preference for point-of-care (POC) testing because of its ease of use and quick results. POC tests allow for quick monitoring and diagnosis, especially in rural or underdeveloped areas.

Biosensor Patent Segmentation

The report will cover the following sections in detail:

Analysis by Product

• Wearable 
  • Wristwear 
  • Eyewear 
  • Footwear 
  • Neckwear 
  • Others 
• Non-Wearable 

Analysis by Technology

• Electrochemical 
• Optical 
  • SPR 
  • Colorimetric Biosensors 
  • Fluorescence Biosensors 
• Piezoelectric 
  • Acoustic Biosensors 
  • Microcantilever Biosensors 
• Thermal Biosensor 
• Nanomechanical 

Biosensor Patent Segmentation Analysis

The breakup based on product includes wearables and non-wearables. A wearable biosensor can be worn on the skin and continuously measures biological signals, like heart rate or blood sugar levels. It makes health tracking easy and accessible by fusing wearable technology with sensors. Real-time health monitoring and data collection in daily life are made possible by this integration.

Detailed technological data will be provided for all specified segments classified in this report.

Biosensor Patent Jurisdiction Analysis

The United States is one of the leading jurisdictions for biosensor patents, having around 106,000+ patents. The presence of big companies, well-established healthcare infrastructure, and advanced research and development activities contributes to the regional patent landscape significantly.

Patent Profile of Key Companies

Among the players with biosensor patent families, new entrants have been identified, which can be either established companies or startups developing their first technology in the biosensor field. Some of the major companies mentioned in this report (a non-exhaustive list) are as follows:

Genentech Inc.

The company was founded in 2001 and has its headquarters in San Diego, California. Advanced biosensor technologies for health monitoring and diagnostics are the company's area of expertise. Their primary goal is to create cutting-edge biosensors that work well with digital health solutions. Their products are designed to improve patient care and research by offering accurate, real-time health data.

F. Hoffmann La Roche

The company is based in Basel, Switzerland, and established in 1896, as a prominent player in the pharmaceutical and diagnostic industries worldwide. As part of its diagnostics division, the company creates sophisticated biosensors with an emphasis on creative approaches to illness detection and treatment. The goal of Roche is to improve healthcare through precision and personalized medicine, and biosensors are essential to this goal.

Other companies include Samsung Electronics Co Ltd, Koninkl Philips Electronics NV, Abbott Diabetes Care Inc., Regeneron Pharma, Dexcom Inc., Zymogenetics Inc., Massachusetts Inst Technology, Novartis AG, Centre Nat Rech Scient, Matsushita Electric Ind Co LTD, and Bristol Myers Squibb Co., among others.

Reasons to Purchase this Report

The biosensor patent report provides information on the intellectual property (IP) position and strategy of key players. This report can help companies and players looking to enter or invest in this field by -

• Competitive Advantage: The landscape reveals the market leaders, potential partners and innovators and makes it understandable which companies have important patents in this field of biosensors.
• Innovation Insights: The patent analysis reveals new innovations and technologies in biosensors.
• Market Positioning: Companies with strong patent portfolios gain a competitive advantage because their intellectual property assets differentiate their products. Understanding their intellectual property strategy reveals the market position of new entrants and potential barriers to entry within the biosensors patent landscape.
• Risk Assessment: In technology-intensive fields such as biosensors, risks of IP infringement are common. Analyzing patent landscapes helps companies assess risk, develop mitigation strategies, and inform licensing, partnering, and acquisition decisions.

Key Questions Answered in the Biosensor Patent Landscape Report

• Who are the key players in the biosensor patent landscape?
• How is the patent portfolio distributed geographically?
• What are the emerging trends in biosensor patents?
• How has the patent landscape evolved over time?
• What are the strategic insights for market players and investors?
• What is the technological focus of patents in the biosensor industry?
• How do patent strategies impact competitive advantage?
• What are the implications of patent filings in biosensor?
• What are the challenges and opportunities in the biosensor patent landscape?
• What are the regulatory and legal considerations?
• What technological innovations have recently emerged in biosensors?

Related Reports

Global Biosensors Market

Switzerland Biosensors Market